ATE535524T1 - Derivate von 2-oxoalkyl-1-piperazin-2-on, verfahren zu deren herstellung und deren therapeutische verwendung - Google Patents

Derivate von 2-oxoalkyl-1-piperazin-2-on, verfahren zu deren herstellung und deren therapeutische verwendung

Info

Publication number: ATE535524T1
Authority: AT; Austria
Prior art keywords: oxoalkyl; piperazin; derivatives; production; therapeutic use
Prior art date: 2008-06-13

Application number

AT09761938T

Other languages

English (en)

Inventor

Marco Baroni

Francoise Bono

Sandrine Delbary-Gossart

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-13

Filing date

2009-06-12

Publication date

2011-12-15

2009-06-12 Application filed by Sanofi Sa filed Critical Sanofi Sa

2011-12-15 Application granted granted Critical

2011-12-15 Publication of ATE535524T1 publication Critical patent/ATE535524T1/de

Links

230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Transplantation (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)

AT09761938T 2008-06-13 2009-06-12 Derivate von 2-oxoalkyl-1-piperazin-2-on, verfahren zu deren herstellung und deren therapeutische verwendung ATE535524T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0803298A FR2932481B1 (fr)	2008-06-13	2008-06-13	Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique.
PCT/FR2009/051117 WO2009150387A1 (fr)	2008-06-13	2009-06-12	Derives de 2-oxo-alkyl-1-piperazin-2-one, leur preparation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
ATE535524T1 true ATE535524T1 (de)	2011-12-15

Family

ID=40305319

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT09761938T ATE535524T1 (de)	2008-06-13	2009-06-12	Derivate von 2-oxoalkyl-1-piperazin-2-on, verfahren zu deren herstellung und deren therapeutische verwendung

Country Status (31)

Country	Link
US (2)	US8247404B2 (de)
EP (1)	EP2310383B8 (de)
JP (1)	JP5476372B2 (de)
KR (1)	KR101601999B1 (de)
CN (1)	CN102124001B (de)
AR (1)	AR072102A1 (de)
AT (1)	ATE535524T1 (de)
AU (1)	AU2009259120B2 (de)
BR (1)	BRPI0915482B8 (de)
CA (1)	CA2726666C (de)
CL (1)	CL2010001432A1 (de)
CO (1)	CO6300943A2 (de)
CY (1)	CY1112417T1 (de)
DK (1)	DK2310383T3 (de)
EA (1)	EA019924B1 (de)
ES (1)	ES2378380T3 (de)
FR (1)	FR2932481B1 (de)
HR (1)	HRP20120187T1 (de)
IL (1)	IL209903A (de)
JO (1)	JO2773B1 (de)
MX (1)	MX2010013694A (de)
MY (1)	MY151228A (de)
NZ (1)	NZ589842A (de)
PL (1)	PL2310383T3 (de)
PT (1)	PT2310383E (de)
RS (1)	RS52252B (de)
SI (1)	SI2310383T1 (de)
TW (1)	TWI400238B (de)
UY (1)	UY31894A (de)
WO (1)	WO2009150387A1 (de)
ZA (1)	ZA201008791B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2932481B1 (fr)	2008-06-13	2010-10-08	Sanofi Aventis	Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique.
FR2932482B1 (fr) *	2008-06-13	2010-10-08	Sanofi Aventis	Nouveaux derives de (phenyl-3,6-dihydro-2h-pyridinyl)- (piperazinyl ponte)-1-alcanone et leur utilisation comme inhibiteurs de p75
FR2953836B1 (fr)	2009-12-14	2012-03-16	Sanofi Aventis	Nouveaux derives (heterocycle-tetrahydro-pyridine)-(piperazinyl)-1-alcanone et (heterocycle-dihydro-pyrrolidine)-(piperazinyl)-1-alcanone et leur utilisation comme inhibiteurs de p75
FR2953839A1 (fr)	2009-12-14	2011-06-17	Sanofi Aventis	Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75
EP2606894A1 (de)	2011-12-20	2013-06-26	Sanofi	Neuartige therapeutische Verwendung von p75-Rezeptorantagonisten
EP2950095B1 (de)	2014-05-28	2018-08-29	Technische Universität Dresden	Zellenbasierte Test- und Screeningverfahren auf Modulatoren von p75NTR-Signalisierung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3236243A1 (de) *	1982-09-30	1984-04-05	Merck Patent Gmbh, 6100 Darmstadt	Schwefelhaltige indolderivate
FR2744448B1 (fr) *	1996-02-02	1998-04-24	Pf Medicament	Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
US6613942B1 (en) *	1997-07-01	2003-09-02	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
WO1999001423A1 (en) *	1997-07-01	1999-01-14	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
WO2000059893A1 (en)	1999-04-06	2000-10-12	Krenitsky Pharmaceuticals Inc.	Neurotrophic thio substituted pyrimidines
UA77526C2 (en) *	2002-06-07	2006-12-15	Sanofi Aventis	Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
FR2862968B1 (fr) *	2003-12-01	2006-08-04	Sanofi Synthelabo	Derives de 4-[(arylmethyl)aminomethyl]piperidine, leur preparation et leur application en therapeutique
FR2862967B1 (fr) *	2003-12-01	2006-08-04	Sanofi Synthelabo	Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique
FR2932481B1 (fr)	2008-06-13	2010-10-08	Sanofi Aventis	Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique.
FR2932482B1 (fr) *	2008-06-13	2010-10-08	Sanofi Aventis	Nouveaux derives de (phenyl-3,6-dihydro-2h-pyridinyl)- (piperazinyl ponte)-1-alcanone et leur utilisation comme inhibiteurs de p75

2008
- 2008-06-13 FR FR0803298A patent/FR2932481B1/fr not_active Expired - Fee Related
2009
- 2009-06-01 JO JO2009197A patent/JO2773B1/en active
- 2009-06-11 AR ARP090102109A patent/AR072102A1/es active IP Right Grant
- 2009-06-11 TW TW098119565A patent/TWI400238B/zh active
- 2009-06-12 MX MX2010013694A patent/MX2010013694A/es active IP Right Grant
- 2009-06-12 PT PT09761938T patent/PT2310383E/pt unknown
- 2009-06-12 AT AT09761938T patent/ATE535524T1/de active
- 2009-06-12 ES ES09761938T patent/ES2378380T3/es active Active
- 2009-06-12 SI SI200930179T patent/SI2310383T1/sl unknown
- 2009-06-12 HR HR20120187T patent/HRP20120187T1/hr unknown
- 2009-06-12 EA EA201170015A patent/EA019924B1/ru not_active IP Right Cessation
- 2009-06-12 CN CN200980131553.8A patent/CN102124001B/zh active Active
- 2009-06-12 EP EP09761938A patent/EP2310383B8/de active Active
- 2009-06-12 WO PCT/FR2009/051117 patent/WO2009150387A1/fr not_active Ceased
- 2009-06-12 KR KR1020117000793A patent/KR101601999B1/ko active Active
- 2009-06-12 RS RS20120082A patent/RS52252B/sr unknown
- 2009-06-12 JP JP2011513037A patent/JP5476372B2/ja active Active
- 2009-06-12 AU AU2009259120A patent/AU2009259120B2/en active Active
- 2009-06-12 MY MYPI20105853 patent/MY151228A/en unknown
- 2009-06-12 DK DK09761938.1T patent/DK2310383T3/da active
- 2009-06-12 UY UY0001031894A patent/UY31894A/es not_active Application Discontinuation
- 2009-06-12 CA CA2726666A patent/CA2726666C/fr active Active
- 2009-06-12 PL PL09761938T patent/PL2310383T3/pl unknown
- 2009-06-12 BR BRPI0915482A patent/BRPI0915482B8/pt active IP Right Grant
- 2009-06-12 NZ NZ589842A patent/NZ589842A/xx not_active IP Right Cessation
2010
- 2010-12-07 ZA ZA2010/08791A patent/ZA201008791B/en unknown
- 2010-12-09 IL IL209903A patent/IL209903A/en active IP Right Grant
- 2010-12-13 US US12/966,408 patent/US8247404B2/en active Active
- 2010-12-13 CO CO10156026A patent/CO6300943A2/es active IP Right Grant
- 2010-12-13 CL CL2010001432A patent/CL2010001432A1/es unknown
2012
- 2012-02-29 CY CY20121100212T patent/CY1112417T1/el unknown
- 2012-07-24 US US13/556,328 patent/US20120289518A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR20110031317A (ko)	2011-03-25
AU2009259120A1 (en)	2009-12-17
RS52252B (sr)	2012-10-31
KR101601999B1 (ko)	2016-03-17
BRPI0915482A2 (pt)	2015-11-10
AR072102A1 (es)	2010-08-04
JP2011522868A (ja)	2011-08-04
PT2310383E (pt)	2012-03-06
IL209903A0 (en)	2011-02-28
JP5476372B2 (ja)	2014-04-23
DK2310383T3 (da)	2012-03-26
CY1112417T1 (el)	2015-12-09
EA201170015A1 (ru)	2011-06-30
CN102124001A (zh)	2011-07-13
JO2773B1 (en)	2014-03-15
FR2932481B1 (fr)	2010-10-08
EA019924B1 (ru)	2014-07-30
MX2010013694A (es)	2011-02-23
CL2010001432A1 (es)	2011-05-13
TW201002686A (en)	2010-01-16
ES2378380T3 (es)	2012-04-11
PL2310383T3 (pl)	2012-04-30
SI2310383T1 (sl)	2012-03-30
TWI400238B (zh)	2013-07-01
NZ589842A (en)	2012-12-21
ZA201008791B (en)	2012-02-29
BRPI0915482B8 (pt)	2021-05-25
FR2932481A1 (fr)	2009-12-18
IL209903A (en)	2014-06-30
UY31894A (es)	2010-01-29
AU2009259120B2 (en)	2014-01-16
CA2726666A1 (fr)	2009-12-17
CO6300943A2 (es)	2011-07-21
EP2310383B8 (de)	2012-04-11
HRP20120187T1 (hr)	2012-03-31
US8247404B2 (en)	2012-08-21
US20120289518A1 (en)	2012-11-15
US20110144122A1 (en)	2011-06-16
CN102124001B (zh)	2014-01-22
WO2009150387A1 (fr)	2009-12-17
HK1158632A1 (en)	2012-07-20
BRPI0915482B1 (pt)	2020-11-24
EP2310383B1 (de)	2011-11-30
EP2310383A1 (de)	2011-04-20
MY151228A (en)	2014-04-30
CA2726666C (fr)	2016-08-16

Publication	Publication Date	Title
DE112010004835A5 (de)	2012-09-20	Wärmedämmendes verglasungselement und verfahren zu dessen herstellung
EP2076326A4 (de)	2012-09-26	Ce-zr-r-o-katalysatoren, artikel mit den ce-zr-r-o-katalysatoren sowie verfahren zur herstellung und verwendung der ce-zr-r-o-katalysatoren
EP4032979C0 (de)	2024-05-01	Faktor-ix-polypeptid-mutant, dessen verwendungen und verfahren zu dessen herstellung
DE112010003417A5 (de)	2012-08-16	Endoskop und verfahren zu dessen verwendung
DE102009035301A8 (de)	2010-07-22	Verfahren zur Herstellung von Dibenz[c,e][1,2]-oxaphosphorin-Derivaten, Amino-dibenz[c,e][1,2]-oxaphosphorin sowie deren Verwendung
PL3133396T3 (pl)	2019-03-29	Sposób leczenia z zastosowaniem leków wychwytujących amoniak
EP3620465C0 (de)	2025-02-19	Verbesserte verfahren zur herstellung, markierung und verwendung von mhc-multimeren
ATE517942T1 (de)	2011-08-15	Behandelte mineralische füllstoffprodukte, verfahren zu deren herstellung und deren verwendungen
DE502005010912D1 (de)	2011-03-10	Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE602007000632D1 (de)	2009-04-16	Laserinterferometer, sowie Verfahren zu dessen Kalibrierung und Verwendung
EP2267833A4 (de)	2012-12-05	Wellenleiter-leistungsverteiler und verfahren zu seiner herstellung
ATE526307T1 (de)	2011-10-15	Hydroxybiphenyl-carbonsäuren und derivate, verfahren zu deren herstellung und deren verwendung
EP2257516A4 (de)	2012-12-12	Verfahren zur herstellung von cyclododecatrien und verfahren zur herstellung von laurolacton
DE112010000715A5 (de)	2012-06-21	Bauteilanordnung und Verfahren zu dessen Herstellung
ATE509923T1 (de)	2011-06-15	Derivate von 7-alkynyl-1,8-naphthyridonen, verfahren zu ihrer herstellung und ihre verwendung in therapeutika
ATE540023T1 (de)	2012-01-15	Neuartige 3-aminoalkyl-1,3-dihydro-2h-indol-2-on- derivate, ihre herstellung und therapeutische verwendung
ATE535524T1 (de)	2011-12-15	Derivate von 2-oxoalkyl-1-piperazin-2-on, verfahren zu deren herstellung und deren therapeutische verwendung
EP2607507A4 (de)	2015-09-23	Hochfestes titanlegierungselement und verfahren zu seiner herstellung
EP2292234A4 (de)	2012-10-10	Zusammensetzungen mit chinazolinderivaten, herstellungsverfahren und ihre verwendung
DE502007001726D1 (de)	2009-11-26	Elastische Einlage, Verfahren zu deren Herstellung und Verwendung
DE502007002958D1 (de)	2010-04-08	Armierte supraleitende wicklung und verfahren zu deren herstellung
EP3483920C0 (de)	2024-03-06	Transistor und verfahren zu dessen herstellung
BRPI0915130A2 (pt)	2019-09-24	derivado de ácido 7h-indolo{2,1-a]{2]-benzapina-10-carboxílico para o tratamento de hepatite c
DE112009003678A5 (de)	2012-10-18	Holz sowie Verfahren und Vorrichtungen zu dessen Herstellung
DE102008046198B8 (de)	2010-04-08	Implantat und Verfahren zu seiner Herstellung sowie deren Verwendung